col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


20 Results       Page 1

 [1] 
Springer-Verlag: International Journal of Peptide Research and Therapeutics
  original article Date Title Authors   All Authors
1 [GO] 2023―Aug―30 Molecular Modelling, Synthesis, and In-Vitro Assay to Identify Potential Antiviral Peptides Targeting the 3-Chymotrypsin-Like Protease of SARS-CoV-2 Ryan Faddis, Sydney Du, James Stewart, Mohammad Mehedi Hasan, Noam Lewit, Md Ackas Ali, et al. (+4)
2 [GO] 2023―Jul―17 Designing a Novel Spike Linear B-Cell Epitopes (SLBE) Protein with High Performance in Sars-Cov2-ELISA Test Majid Esmaelizad, Maedeh Hamidizadeh, Nazanin Esmaelizad, Mohammad Doroudian, Mohammad Ranjbar, Mohsen Lotfi
3 [GO] 2023―May―30 Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients Motahareh Zeinivand, Masoomeh Sharifi, Gholamhossein Hassanshahi, Seyed Ershad Nedaei
4 [GO] 2022―Aug―22 SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective Abdo A. Elfiky, Ibrahim M. Ibrahim, Alaa M. Elgohary
5 [GO] 2022―Apr―19 Peptide-Based Vaccines and Therapeutics for COVID-19 Pritam V. Bagwe, Priyal V. Bagwe, Sai Srinivas Ponugoti, Shreerang V. Joshi
6 [GO] 2022―Mar―16 Immunogenic Epitope-Based Vaccine Prediction from Surface Glycoprotein of MERS-CoV by Deploying Immunoinformatics Approach Truc Ly Nguyen, Youngho Lee, Heebal Kim
7 [GO] 2022―Jan―24 Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19 Aparajita Sen, Arti Nigam, Meenakshi Vachher
8 [GO] 2022―Jan―21 Exploring Structural Mechanism of COVID-19 Treatment with Glutathione as a Potential Peptide Inhibitor to the Main Protease: Molecular Dynamics Simulation and MM/PBSA Free Energy Calculations Study Abderahmane Linani, Khedidja Benarous, Leila Bou-Salah, Mohamed Yousfi, Souraya Goumri-Said
9 [GO] 2022―Jan―03 Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus Yasaman Behzadipour, Shiva Hemmati
10 [GO] 2022―Jan―03 In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein Gunderao H. Kathwate
11 [GO] 2021―Dec―13 In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern Sajjan Rajpoot, Kundan Solanki, Ashutosh Kumar, Kam Y. J. Zhang, Soni Savai Pullamsetti, Rajkumar Savai, et al. (+3)
12 [GO] 2021―Dec―09 In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides Mohammad Moradi, Reza Golmohammadi, Ali Najafi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi, Reza Mirnejad
13 [GO] 2021―Jul―10 Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee
14 [GO] 2021―Jul―10 New Computational Approach for Peptide Vaccine Design Against SARS-COV-2 Subhamoy Biswas, Smarajit Manna, Ashesh Nandy, Subhash C. Basak
15 [GO] 2021―Apr―16 Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics Richa Jain, Ankit Jain, Santosh kumar Verma
16 [GO] 2021―Apr―16 Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection Abbas Jafari, Sonia Sadeghpour, Hojat Ghasemnejad-Berenji, Sarvin Pashapour, Morteza Ghasemnejad-Berenji
17 [GO] 2021―Apr―08 Identification of Potential Peptide Inhibitors of ACE-2 Target of SARS-CoV-2 from Buckwheat & Quinoa Ashok Nanjaiah Rangaswamy, Arpitha Ashok, Pradeep Hanumanthappa, Aparanji Sinduvalli Chandrashekaramurthy, Monika Kumbaiah, Pratibha Hiregouda, et al. (+2)
18 [GO] 2021―Mar―17 In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2 M A. Siddiqa, D. S. Rao, G. Suvarna, V. K. Chennamachetty, M. K. Verma, M. V. R. Rao
19 [GO] 2020―Nov―10 Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach Janish Kumar, Rahila Qureshi, Someswar R. Sagurthi, Insaf Ahmed Qureshi
20 [GO] 2020―Sep―28 Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease Vijayakumar Balakrishnan, Karthik Lakshminarayanan
 [1] 

20 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.013 sec